NIAID supports the study of global research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases and conditions. In addition to advancing these scientific goals, NIAID global research helps to improve the health of millions of people around the world, to protect the United States against infectious disease threats, and to promote international economic and political stability. Together, these efforts establish NIAID as a leader in global health.
NIH Begins Early Human Clinical Trial of VSV Ebola Vaccine—Oct. 22, 2014
Media Availability: NIH Grants License Agreement for Candidate Ebola Vaccines—Oct. 15, 2014
Media Availability: NIH-Supported Scientists Unveil Structure, Dynamics of Key HIV Molecules—Oct. 8, 2014
Candidate H7N9 Avian Flu Vaccine Works Better with Adjuvant—Oct. 7, 2014
All Global Research News Releases
News From NIAID-Supported Institutions
Last Updated October 21, 2014